AGIO vs MTD · rev $65.5M vs P/E 27, rev $1.97B
Agios Pharm (AGIO) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
AGIO currently screens at market cap $1.68B. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the AGIO and MTD stock pages for the full models.
Not investment advice.